NHS App Overhaul to Speed Up Rare Cancer Trial Access
The NHS App is getting a slick new upgrade designed to help rare cancer patients find groundbreaking clinical trials faster than ever. The government’s digital-first push aims to connect patients directly to cutting-edge treatments, slashing long delays in the referral process.
Search, Match, Alert: The Future of Cancer Trial Access
- Patients can soon browse trials through the app’s research database and request contact instantly.
- Automatic alerts will notify users when new trials matching their condition become available.
- This revolution removes the usual slow, hit-or-miss doctor referrals.
Powered by the “Be Part of Research” service, already helping 100,000+ people join 160+ studies, this integration could put life-saving treatments just a tap away for many.
Government Backing: National Cancer Plan & Rare Cancers Bill
This digital boost supports the National Cancer Plan and the Rare Cancers Bill championed by Dr Scott Arthur MP. The new legislation targets better rare cancer research and guarantees steady trial access across England within three years.
Already, brain cancer research has bagged a £32.3 million investment since July 2024 to accelerate trials, sharpen precision medicine, and cultivate future research stars.
Brain Tumours: UK’s Deadliest Cancer for Under-40s
Brain tumours kill over 10,000 people yearly and remain the deadliest cancer for children and adults under 40. Survival rates lag far behind other cancers.
The government is fast-tracking trial referrals by recruiting top cancer specialists and appointing a national lead for rare cancers via the National Institute for Health and Care Research. This role aims to open up trials to patients nationwide.
Voices on the Frontline
Health Secretary Wes Streeting said: “Rare cancer patients face huge challenges in a system never designed for them. The National Cancer Plan is a real step-change, giving researchers the tools and patients the hope they deserve.”
Cancer Research UK will receive £3 million this year to launch Brain Tumour Centres of Excellence, boosting research, treatment, and survival across all ages.
The government’s goal: by 2035, the UK will lead Europe in survival rates for 14 rare, deadly cancers — with brain cancer top of the list.
Real Lives Changed
Meet Mike Shurmer, 65, from Swindon. Diagnosed in 2023 with just a year to live, he joined the NIHR-funded FUTURE-GB trial. Using cutting-edge techniques, doctors removed more of his tumour without damaging his brain function. Now on ongoing care with a portable medical device, Mike has raised £12,000 for Brainstorm Charity and advocates for trial participation.
Professor Peter Johnson, NHS England’s National Clinical Director for Cancer, said: “People with rare cancers must know their options. We’re making it easier for thousands to access targeted treatments and drive critical research forward.”
The Road Ahead: Bigger, Faster, Smarter Trials
The plan includes a new Cancer Clinical Trials Accelerator via the NIHR Industry Hub. This single pathway will simplify investment routes to speed up trial launch, enlarge participant numbers, and boost reliability.
The NIHR Brain Tumour Research Consortium has secured up to £25.5 million, uniting 48 organisations to fast-track new treatments and evaluation for adults and children alike.
